XWELL Return on Tangible Equity 2010-2024 | XWEL
Current and historical return on tangible equity values for XWELL (XWEL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| XWELL Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2024-09-30 | $-0.02B | $0.01B | -98.36% |
| 2024-06-30 | $-0.02B | $0.02B | -118.92% |
| 2024-03-31 | $-0.03B | $0.02B | -118.18% |
| 2023-12-31 | $-0.03B | $0.02B | -108.41% |
| 2023-09-30 | $-0.04B | $0.03B | -114.73% |
| 2023-06-30 | $-0.03B | $0.03B | -81.53% |
| 2023-03-31 | $-0.03B | $0.04B | -68.34% |
| 2022-12-31 | $-0.03B | $0.04B | -52.89% |
| 2022-09-30 | $-0.02B | $0.05B | -21.48% |
| 2022-06-30 | $-0.00B | $0.07B | -3.47% |
| 2022-03-31 | $0.00B | $0.08B | 1.09% |
| 2021-12-31 | $0.00B | $0.10B | 4.15% |
| 2021-09-30 | $-0.01B | $0.10B | -15.14% |
| 2021-06-30 | $-0.03B | $0.09B | -32.30% |
| 2021-03-31 | $-0.08B | $0.10B | -127.56% |
| 2020-12-31 | $-0.09B | $0.08B | -247.62% |
| 2020-09-30 | $-0.08B | $0.05B | -572.41% |
| 2020-06-30 | $-0.08B | $0.02B | -16400.00% |
| 2020-03-31 | $-0.03B | $-0.01B | 527.27% |
| 2019-12-31 | $-0.02B | $-0.01B | 840.00% |
| 2019-09-30 | $-0.02B | $-0.00B | -2800.00% |
| 2019-06-30 | $-0.02B | $0.00B | -633.33% |
| 2019-03-31 | $-0.02B | $0.00B | -340.00% |
| 2018-12-31 | $-0.04B | $0.00B | -524.14% |
| 2018-09-30 | $-0.04B | $0.01B | -420.00% |
| 2018-06-30 | $-0.04B | $0.01B | -352.00% |
| 2018-03-31 | $-0.05B | $0.01B | -341.82% |
| 2017-12-31 | $-0.03B | $0.02B | -190.16% |
| 2017-09-30 | $-0.02B | $0.02B | -115.79% |
| 2017-06-30 | $-0.02B | $0.01B | -111.39% |
| 2017-03-31 | $-0.03B | $0.02B | -119.54% |
| 2016-12-31 | $-0.02B | $0.03B | -107.87% |
| 2016-09-30 | $-0.00B | $0.02B | -20.51% |
| 2016-06-30 | $-0.01B | $0.02B | -72.13% |
| 2016-03-31 | $-0.01B | $0.02B | -81.82% |
| 2015-12-31 | $-0.01B | $0.02B | -141.18% |
| 2015-09-30 | $-0.10B | $0.00B | -1434.48% |
| 2015-06-30 | $-0.10B | $0.00B | -866.67% |
| 2015-03-31 | $-0.11B | $0.01B | -583.33% |
| 2014-12-31 | $-0.11B | $0.01B | -512.94% |
| 2014-09-30 | $-0.05B | $0.02B | -214.43% |
| 2014-06-30 | $-0.05B | $0.03B | -185.45% |
| 2014-03-31 | $-0.05B | $0.02B | -173.33% |
| 2013-12-31 | $-0.05B | $0.03B | -152.52% |
| 2013-09-30 | $-0.05B | $0.03B | -119.25% |
| 2013-06-30 | $-0.04B | $0.04B | -141.59% |
| 2013-03-31 | $-0.03B | $0.04B | -167.57% |
| 2012-12-31 | $-0.02B | $0.05B | -247.06% |
| 2012-09-30 | $-0.01B | $-0.01B | 200.00% |
| 2012-06-30 | $-0.00B | $-0.00B | 1600.00% |
| 2012-03-31 | $-0.00B | $0.00B | 800.00% |
| 2011-12-31 | $-0.00B | $0.00B | 300.00% |
| 2011-09-30 | $-0.01B | $-0.00B | 333.33% |
| 2011-06-30 | $-0.01B | $-0.00B | 933.33% |
| 2011-03-31 | $-0.01B | $-0.00B | -2000.00% |
| 2010-12-31 | $-0.01B | $0.00B | -1466.67% |
| 2010-06-30 | $-0.01B | $0.00B | -1066.67% |
| 2010-03-31 | $-0.00B | inf% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.008B | $0.030B |
| XWELL Inc. is a health and wellness holding company. Its operating brands include XpresCheck(R), XpresSpa(R), Treat(TM) and HyperPointe. XpresSpa is a retailer of wellness services and related products. Treat is a travel health and wellness brand. XpresCheck is a provider of Covid-19 screening and diagnostic testing in partnership with the CDC and Concentric by Ginkgo. HyperPointe is a digital healthcare and data analytics relationship company. XWELL Inc., formerly known as XpresSpa Group Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $86.493B | 10.73 |
| Cencora (COR) | United States | $43.979B | 16.54 |
| DiDi Global (DIDIY) | China | $22.358B | 0.00 |
| Natera (NTRA) | United States | $21.439B | 0.00 |
| ICON (ICLR) | Ireland | $17.593B | 15.67 |
| Viatris (VTRS) | United States | $14.801B | 4.56 |
| Avantor (AVTR) | United States | $14.538B | 21.80 |
| Revvity (RVTY) | United States | $13.672B | 23.75 |
| BioMerieux (BMXMF) | France | $12.468B | 0.00 |
| CochLear (CHEOY) | Australia | $12.010B | 0.00 |
| Solventum (SOLV) | United States | $11.499B | 0.00 |
| Doximity (DOCS) | United States | $10.879B | 64.03 |
| Medpace Holdings (MEDP) | United States | $10.651B | 30.01 |
| Charles River Laboratories (CRL) | United States | $9.526B | 18.41 |
| HealthEquity (HQY) | United States | $8.292B | 41.60 |
| Sonic Healthcare (SKHHY) | Australia | $8.215B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.290B | 29.28 |
| Amplifon S.p.A (AMFPF) | Italy | $5.864B | 29.89 |
| Sotera Health (SHC) | United States | $3.838B | 20.53 |
| Organon (OGN) | United States | $3.794B | 3.83 |
| BrightSpring Health Services (BTSG) | United States | $3.037B | 64.59 |
| Surgery Partners (SGRY) | United States | $2.671B | 30.45 |
| Concentras Parent (CON) | United States | $2.608B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.294B | 0.00 |
| GeneDx Holdings (WGS) | United States | $2.126B | 0.00 |
| Premier (PINC) | United States | $2.067B | 10.76 |
| Alignment Healthcare (ALHC) | United States | $2.055B | 0.00 |
| PACS (PACS) | United States | $1.995B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.711B | 44.90 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.651B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.594B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.246B | 0.00 | |
| Progyny (PGNY) | United States | $1.237B | 25.05 |
| Embecta (EMBC) | United States | $1.179B | 8.24 |
| Pediatrix Medical (MD) | United States | $1.177B | 11.52 |
| CareDx (CDNA) | United States | $1.149B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.891B | 6.03 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.787B | 0.00 |
| SBC Medicals (SBC) | United States | $0.553B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.550B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.509B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.444B | 0.00 |
| DocGo (DCGO) | United States | $0.431B | 16.23 |
| Enhabit (EHAB) | United States | $0.385B | 33.30 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.276B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.268B | 0.00 |
| LifeMD (LFMD) | United States | $0.213B | 0.00 |
| Biodesix (BDSX) | United States | $0.212B | 0.00 |
| MultiPlan (MPLN) | United States | $0.198B | 0.00 |
| Beauty Health (SKIN) | United States | $0.185B | 0.00 |
| Nutex Health (NUTX) | United States | $0.173B | 0.00 |
| ModivCare (MODV) | United States | $0.163B | 8.83 |
| So-Young (SY) | China | $0.093B | 15.80 |
| Ascend Wellness Holdings (AAWH) | United States | $0.081B | 0.00 |
| NeueHealth (NEUE) | United States | $0.062B | 1.65 |
| IceCure Medical (ICCM) | Israel | $0.051B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.049B | 0.00 |
| OncoCyte (OCX) | United States | $0.036B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.025B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.025B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.024B | 0.00 |
| Oncology Institute (TOI) | United States | $0.017B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| KindlyMD (KDLY) | United States | $0.006B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |